Clinical trial

Placebo Controlled, Randomized, Double-blind, Multi-center Study to Investigate the Efficacy and Tolerability of BAY58-2667

NCT00559650

StatusTERMINATED

Study typeINTERVENTIONAL

Start date2007-12-01

PhasePHASE2

Study timeline

Study start (unknown)2007-12-01Date precision: month

Registry last updated2017-04-18

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Congestive Heart Failureunresolved

Interventions

PlaceboDRUG

Cinaciguat (BAY58-2667)DRUG

Sponsors & collaborators

Bayerlead sponsor

Mapped research locations

MoscowRussia4 PragueCzechia2 BrnoCzechia2 BostonMassachusetts, United States1 DallasTexas, United States1 TorontoOntario, Canada1 CincinnatiOhio, United States1 San DiegoCalifornia, United States1 Washington D.C.District of Columbia, United States1 BudapestHungary1 KrakowPoland1 JerusalemIsrael1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00559650 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.